Aprotinin modulation of platelet activation in patients undergoing cardiopulmonary bypass operations.

[1]  J. Fareed,et al.  Flow Cytometric Evaluation of Platelet Activation by Ionic or Nonionic Contrast Media and Modulation by Heparin and Recombinant Hirudin , 1995, Investigative radiology.

[2]  R. Pifarré Blood conservation with aprotinin , 1995 .

[3]  J. Soria,et al.  Postoperative Hemostasis and Fibrinolysis in Patients Undergoing Cardiopulmonary Bypass with or without Aprotinin Therapy , 1994, Thrombosis and Haemostasis.

[4]  C. Cerletti,et al.  Polymorphonuclear Leukocyte-Platelet Interaction: Role of P-Selectin in Thromboxane B2 and Leukotriene C4 Cooperative Synthesis , 1994, Thrombosis and Haemostasis.

[5]  S. Funderud,et al.  Complement-mediated permeabilization of platelets by monoclonal antibodies to CD9: inhibition by leupeptin, and effects on the GP Ib-actin-binding protein system. , 1994, Thrombosis research.

[6]  Z. Su,et al.  Mechanism of the preserving effect of aprotinin on platelet function and its use in cardiac surgery , 1993 .

[7]  B. Pasche,et al.  The platelet function defect of cardiopulmonary bypass. , 1993, Blood.

[8]  R. Mohr,et al.  Platelet protection by low-dose aprotinin in cardiopulmonary bypass: electron microscopic study. , 1993, The Annals of thoracic surgery.

[9]  A. Lusky,et al.  Aprotinin Prevents Cardiopulmonary Bypass‐Induced Platelet Dysfunction: A Scanning Electron Microscope Study , 1992, Circulation.

[10]  J. Mathew,et al.  Cardiopulmonary bypass induces leukocyte-platelet adhesion. , 1992, Blood.

[11]  J. Soria,et al.  Hemostasis in Patients Undergoing Extracorporeal Circulation: The Effect of Aprotinin (Trasylol) , 1991, Thrombosis and Haemostasis.

[12]  J. E. Doran,et al.  Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass. , 1991, The Journal of thoracic and cardiovascular surgery.

[13]  W. van Oeveren,et al.  Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. , 1990, The Journal of thoracic and cardiovascular surgery.

[14]  J. Caprini,et al.  Decreased Platelet Number and Function and Increased Fibrinolysis Contribute to Postoperative Bleeding in Cardiopulmonary Bypass Patients , 1988, Thrombosis and Haemostasis.

[15]  J. Hoxie,et al.  Detection of activated platelets in whole blood using activation- dependent monoclonal antibodies and flow cytometry , 1987 .